ArticlePloS one2026

Correction: Risk of hepatitis B virus reactivation in the treatment of HBsAg and HBV DNA double-negative lymphoma patients.

PLOS One StaffPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.